16-19555551-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000251143.9(VPS35L):c.89C>T(p.Ala30Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000135 in 1,552,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000251143.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS35L | ENST00000251143.9 | c.89C>T | p.Ala30Val | missense_variant | 1/31 | 1 | ENSP00000251143 | |||
VPS35L | ENST00000542263.5 | c.-179C>T | 5_prime_UTR_variant | 1/28 | 2 | ENSP00000442468 | ||||
VPS35L | ENST00000544670.5 | c.-204+231C>T | intron_variant | 5 | ENSP00000456425 | |||||
VPS35L | ENST00000539322.5 | c.89C>T | p.Ala30Val | missense_variant, NMD_transcript_variant | 1/12 | 5 | ENSP00000438852 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000143 AC: 20AN: 1400704Hom.: 0 Cov.: 30 AF XY: 0.0000101 AC XY: 7AN XY: 691928
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.89C>T (p.A30V) alteration is located in exon 1 (coding exon 1) of the C16orf62 gene. This alteration results from a C to T substitution at nucleotide position 89, causing the alanine (A) at amino acid position 30 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at